Você procurou por: dipeptidylpeptidázy (Tcheco - Inglês)

inhibitory dipeptidylpeptidázy 4
dipeptidyl peptidase iv inhibitors

sitagliptin je inhibitor dipeptidylpeptidázy 4 (dpp-4).
sitagliptin is a dipeptidyl-peptidase-4 (dpp 4) inhibitor.

léčivá látka v přípravku ristaben, sitagliptin, je inhibitor dipeptidylpeptidázy 4 (dpp-4).
the active substance in ristaben, sitagliptin, is a dipeptidyl-peptidase-4 (dpp 4) inhibitor.

alogliptin patří do skupiny léčivých látek nazývaných inhibitory dpp-4 (inhibitory dipeptidylpeptidázy-4).
alogliptin belongs to a group of medicines called dpp-4 inhibitors (dipeptidyl peptidase-4 inhibitors).

přípravek xultophy nebyl studován v kombinaci s inhibitory dipeptidylpeptidázy 4 (dpp-4), glinidy ani prandiálním inzulinem.
xultophy has not been studied in combination with dipeptidyl peptidase 4 (dpp-4) inhibitors, glinides or prandial insulin.

farmakoterapeutická skupina: léky používané při diabetu inhibitory dipeptidylpeptidázy 4 (dpp-4), atc kód: a10bh01.
pharmacotherapeutic group: drugs used in diabetes, dipeptidyl peptidase 4 (dpp-4) inhibitors, atc code: a10bh01

již od stanovení diagnózy diabetu byla u našeho pacienta zahájena kombinační léčba inhibitory dipeptidylpeptidázy 4 (dpp-4) neboli gliptiny a metforminem.
in our patient the combined treatment with inhibitors of dipeptidylpeptidase 4 (dpp-4) or gliptines and metformin was initiated at the time of the initial diagnosis.

sitagliptin fosfát sitagliptinu je perorálně aktivní, silný a vysoce selektivní inhibitor enzymu dipeptidylpeptidázy 4 (dpp- 4), určený k léčbě diabetu typu 2.
sitagliptin sitagliptin phosphate is an orally-active, potent, and highly selective inhibitor of the dipeptidyl peptidase 4 (dpp-4) enzyme for the treatment of type 2 diabetes.

dipeptidylpeptidáza 4
dipeptidyl peptidase iv